Regeneron, Sanofi Win Approval for Their First Immuno-Oncology Drug

Regeneron Pharmaceuticals Inc. and Sanofi won U.S. Food and Drug Administration approval for their first immuno-oncology drug, a therapy that the companies hope will jump-start their cancer joint venture.